Repligen Corporation (RGEN)
NASDAQ: RGEN · IEX Real-Time Price · USD
166.31
+7.95 (5.02%)
At close: May 2, 2024, 4:00 PM
158.14
-8.17 (-4.91%)
After-hours: May 2, 2024, 4:45 PM EDT
Repligen Revenue
Repligen had revenue of $607.45M in the twelve months ending March 31, 2024, down -21.90% year-over-year. Revenue in the quarter ending March 31, 2024 was $151.35M, a -17.14% decrease year-over-year. In the year 2023, Repligen had annual revenue of $638.76M, a decrease of -20.31%.
Revenue (ttm)
$607.45M
Revenue Growth
-21.90%
P/S Ratio
15.27
Revenue / Employee
$340,690
Employees
1,783
Market Cap
9.28B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 638.76M | -162.77M | -20.31% |
Dec 31, 2022 | 801.54M | 131.00M | 19.54% |
Dec 31, 2021 | 670.53M | 304.27M | 83.08% |
Dec 31, 2020 | 366.26M | 96.02M | 35.53% |
Dec 31, 2019 | 270.25M | 76.21M | 39.28% |
Dec 31, 2018 | 194.03M | 52.80M | 37.38% |
Dec 31, 2017 | 141.24M | 36.70M | 35.10% |
Dec 31, 2016 | 104.54M | 21.00M | 25.14% |
Dec 31, 2015 | 83.54M | 19.99M | 31.45% |
Dec 31, 2014 | 63.55M | -4.62M | -6.78% |
Dec 31, 2013 | 68.17M | 5.90M | 9.48% |
Dec 31, 2012 | 62.27M | 34.98M | 128.16% |
Mar 31, 2011 | 27.29M | 6.32M | 30.14% |
Mar 31, 2010 | 20.97M | -8.39M | -28.58% |
Mar 31, 2009 | 29.36M | 10.07M | 52.16% |
Mar 31, 2008 | 19.30M | 5.22M | 37.10% |
Mar 31, 2007 | 14.07M | 1.16M | 9.01% |
Mar 31, 2006 | 12.91M | 3.55M | 37.94% |
Mar 31, 2005 | 9.36M | 2.45M | 35.38% |
Mar 31, 2004 | 6.91M | -857.44K | -11.03% |
Mar 31, 2003 | 7.77M | 3.47M | 80.67% |
Mar 31, 2002 | 4.30M | 2.05M | 90.74% |
Mar 31, 2001 | 2.26M | -648.72K | -22.34% |
Mar 31, 2000 | 2.90M | 526.46K | 22.14% |
Mar 31, 1999 | 2.38M | -7.57K | -0.32% |
Mar 31, 1998 | 2.38M | -1.42M | -37.26% |
Mar 31, 1997 | 3.80M | -7.06M | -64.99% |
Mar 31, 1996 | 10.86M | -6.08M | -35.91% |
Mar 31, 1995 | 16.94M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tenet Healthcare | 20.56B |
Henry Schein | 12.34B |
Encompass Health | 4.80B |
AptarGroup | 3.54B |
Teleflex | 2.97B |
Chemed | 2.29B |
Qiagen | 1.97B |
Stevanato Group | 1.21B |
RGEN News
- 1 day ago - Repligen Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 15 days ago - Repligen to Report First Quarter 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Repligen Appoints Maggie A. Pax to Board of Directors - GlobeNewsWire
- 2 months ago - Repligen Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 3 months ago - Repligen to Report Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 4 months ago - Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements - GlobeNewsWire
- 6 months ago - UPDATE – Repligen Announces Publication of the Company's 2022 Sustainability Report - GlobeNewsWire